Open AccessJournal Article
Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer.
Ovidiu Zlatian,Maria Comănescu,AF Rosu,L Rosu,Mihai Cruce,Alice Elena Găman,Cornelia Daniela Călina,Veronica Sfredel +7 more
Reads0
Chats0
TLDR
The study demonstrated the intratumoral and intertumoral heterogeneity, expressed at phenotypic level in colorectal adenocarcinomas, and found a significant positive correlation between KRAS protein expression and BCL2 and TP53 expression.Abstract:
Introduction Intratumoral heterogeneity implies the existence of differences between tumor cells, which can best be shown by histochemical and immunohistochemical techniques. The histological study is a mandatory step in any research aimed at characterizing tumor heterogeneity. Immunohistochemistry (IHC) also plays an important role in the differentiation of tumor types, assessing aggressiveness. Materials and methods Investigated group consisted of 50 patients with colorectal adenocarcinoma, for each were recorded clinicopathological data and harvested samples intraoperatively, which were included in paraffin blocks. We perform Hematoxylin-Eosin staining for histological grade and other indices. IHC study used Avidin-Biotin-Peroxidase (ABC), with the markers: CK7, CK20, MUC1, MUC2, Ki-67, PCNA, p53, KRAS, BCL2, PTEN, EGFR. The resulting data were analyzed by statistical methods. Results Most of colorectal adenocarcinoma studied had no special histological features and had G2 grade. IHC detected in most cases the CK20+÷CK7- phenotype (78%) and MUC1 (74%) protein expression. The proliferation markers (Ki-67 and PCNA) were present in all tumor mass with a variable index, which shows high intratumoral heterogeneity, but p53 and KRAS were distributed more uniformly, showing low intratumoral heterogeneity. PTEN was expressed nuclearly in 86% of the cases and EGFR in 42%. Conclusions The expression profiles of cytokeratins and mucins in the colorectal adenocarcinomas are useful in defining tumor phenotypes with different prognosis and therapy. We found a significant positive correlation between KRAS protein expression and BCL2 and TP53 expression. The study demonstrated the intratumoral and intertumoral heterogeneity, expressed at phenotypic level.read more
Citations
More filters
Journal ArticleDOI
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Aristides M. Tsatsakis,Aristides M. Tsatsakis,Daniela Calina,Luca Falzone,Dimitrios Petrakis,Radu Mitrut,Vasileios Siokas,Manuela Pennisi,Giuseppe Lanza,Massimo Libra,Sotirios G. Doukas,Sotirios G. Doukas,Panagiotis G Doukas,Leena Kavali,Amar Bukhari,Chiranjeevi Gadiparthi,Dimitra P. Vageli,Diamantis P. Kofteridis,Demetrios A. Spandidos,Monica Maria Bastos Paoliello,Michael Aschner,Anca Oana Docea +21 more
TL;DR: The present review summarizes the current, though admittedly fluid knowledge on the pathophysiology and symptoms of COVID-19 infection and contributes to a more complete understanding of the disease, and may drive the direction of new research.
Journal ArticleDOI
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.
Javad Sharifi-Rad,Cristina Quispe,Monica Butnariu,Lia Sanda Rotariu,Oksana Sytar,Simona Sestito,Simona Sestito,Simona Rapposelli,Simona Rapposelli,Muhammad Akram,Mehwish Iqbal,Akash Krishna,Nanjangud Venkatesh Anil Kumar,Susana S. Braga,Susana M. Cardoso,Karolina Jafernik,Halina Ekiert,Natália Cruz-Martins,Natália Cruz-Martins,Agnieszka Szopa,Marcelo Villagrán,Lorena Mardones,Miquel Martorell,Anca Oana Docea,Daniela Calina +24 more
TL;DR: The use of chitosan-based nanoparticles in nanomedicine, biomedical engineering, discovery and development of new drugs has been discussed in this article, with the focus on properties, usage safety, and potentially valuable applications.
Journal ArticleDOI
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).
Taxiarchis Konstantinos Nikolouzakis,Loukia Vassilopoulou,Persefoni Fragkiadaki,Theodoros Mariolis Sapsakos,Georgios Z. Papadakis,Demetrios A. Spandidos,Aristides M. Tsatsakis,John Tsiaoussis +7 more
TL;DR: This review aims to describe the most accepted biomarkers among those proposed for use in CRC divided based on the clinical specimen that is examined (tissue, faeces or blood) along with their restrictions.
Journal ArticleDOI
Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy
Javad Sharifi-Rad,Cristina Quispe,Jayanta Kumar Patra,Yengkhom Disco Singh,Manasa Kumar Panda,Gitishree Das,Charles Oluwaseun Adetunji,Olugbenga Samuel Michael,Oksana Sytar,Oksana Sytar,Letizia Polito,Jelena Živković,Natália Cruz-Martins,Marta Klimek-Szczykutowicz,Halina Ekiert,Muhammad Iqbal Choudhary,Seyed Abdulmajid Ayatollahi,Seyed Abdulmajid Ayatollahi,Bekzat Tynybekov,Farzad Kobarfard,Ana Covilca Muntean,Ioana Grozea,Sevgi Durna Daştan,Monica Butnariu,Agnieszka Szopa,Daniela Calina +25 more
TL;DR: Paclitaxel is a broad-spectrum anticancer compound derived mainly from a medicinal plant, in particular from the bark of the yew tree Taxus brevifolia Nutt.
Journal ArticleDOI
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine
P. P. Dhyani,Cristina Quispe,Eshita Sharma,Amit Bahukhandi,Priyanka Sati,Dharam Chand Attri,Agnieszka Szopa,Javad Sharifi-Rad,Anca Oana Docea,Ileana Mardare,Daniela Calina,William C. Cho +11 more
TL;DR: In this article , a spectrum of promising secondary plant metabolites such as colchicine, vinblastine and vincamine have been reviewed in order to develop an effective, affordable, and cost effective cancer management program using these alkaloids.
References
More filters
Journal ArticleDOI
Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery
Daniel G Booth,Masatoshi Takagi,Luis Sanchez-Pulido,E Petfalski,Giulia Vargiu,Kumiko Samejima,Naoko Imamoto,Chris P. Ponting,David Tollervey,William C. Earnshaw,Paola Vagnarelli +10 more
TL;DR: In this paper, the authors report that the nucleolar protein Ki-67 is required for the assembly of the perichromosomal compartment in human cells, which is a cell-cycle regulated protein phosphatase 1-binding protein that is involved in phospho-regulation of B23/nucleophosmin.
Journal ArticleDOI
KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.
Paloma Cejas,Miriam López-Gómez,Miriam López-Gómez,Cristina Aguayo,Rosario Madero,Javier de Castro Carpeño,Cristobal Belda-Iniesta,Jorge Barriuso,Victor Moreno Garcia,J. Larrauri,Rocío López,Enrique Casado,Manuel González-Barón,Jaime Feliu +13 more
TL;DR: A role for KRAS mutations in the propensity of primary colorectal tumors to metastasize to the lung is suggested.
Journal ArticleDOI
Antibody Elution Method for Multiple Immunohistochemistry on Primary Antibodies Raised in the Same Species and of the Same Subtype
Daniel Pirici,Laurentiu Mogoanta,Samir Kumar-Singh,Ionica Pirici,Claudiu Mărgăritescu,Simionescu C,Radu Stanescu +6 more
TL;DR: This work presents a procedure that elutes the antibodies after a first round of immunolabeling, which, in combination with precipitation-based detection systems, allows multiple IHC rounds even for primary antibodies raised in the same species and IgG isotype.
Journal ArticleDOI
The Ki-67 protein interacts with members of the heterochromatin protein 1 (HP1) family: a potential role in the regulation of higher-order chromatin structure.
Thomas Scholzen,Elmar Endl,Claudia Wohlenberg,Sjaak van der Sar,Ian G. Cowell,Johannes Gerdes,Prim B. Singh +6 more
TL;DR: It is shown that a C‐terminal domain of pKi‐67 (Kon21) is able to bind to all three members of the mammalian heterochromatin protein 1 (HP1) family in vitro and in vivo, and this interaction can be manipulated in living cells, as evidenced by ectopic expression of GFP‐tagged HP1 proteins in HeLa cells, which results in a dramatic relocalization of endogenous pKI‐67.
Journal ArticleDOI
Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
TL;DR: CK7 positivity or CK20 negativity does not rule out a colorectal origin of metastatic carcinoma, and CK7 expression was more common in tumors with lymph node metastasis than in non-metastatic tumors.